Shinpoong Pharmaceutical Co Ltd banner

Shinpoong Pharmaceutical Co Ltd
KRX:019170

Watchlist Manager
Shinpoong Pharmaceutical Co Ltd Logo
Shinpoong Pharmaceutical Co Ltd
KRX:019170
Watchlist
Price: 10 250 KRW 1.49% Market Closed
Market Cap: ₩565.6B

Shinpoong Pharmaceutical Co Ltd
Investor Relations

Shinpoong Pharmaceutical Co. Ltd. engages in the manufacture and sales of pharmaceutical products. The company is headquartered in Ansan, Gyeonggi-Do. The firm's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The firm also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The firm distributes its products within domestic market and to overseas markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Jei-Man Ryu
Chief Executive Officer
No Bio Available
Mr. Chang-Kyun Kim
President
No Bio Available

Contacts

Address
GYEONGGI-DO
Ansan
7, Wonsi-ro, Danwon-gu
Contacts
+82314916191
shinpoong.co.kr
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett